Pictet Asset Management’s ResMed RMD Stock Holding History

Pictet Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17M	Buy	87,286 +25,788	+42%	+$5.34M	0.02%	576
2026 Q1	$13.8M	Sell	61,498 -12,152	-16%	-$3.03M	0.01%	577
2025 Q4	$17.7M	Sell	73,650 -42,929	-37%	-$11M	0.02%	551
2025 Q3	$31.9M	Buy	116,579 +49,474	+74%	+$13.5M	0.03%	419
2025 Q2	$17.3M	Sell	67,105 -1,817	-3%	-$433K	0.02%	543
2025 Q1	$15.4M	Sell	68,922 -384	-0.6%	-$89.6K	0.02%	555
2024 Q4	$15.8M	Sell	69,306 -1,029	-1%	-$248K	0.02%	561
2024 Q3	$17.2M	Sell	70,335 -3,943	-5%	-$881K	0.02%	533
2024 Q2	$14.2M	Sell	74,278 -1,113	-1%	-$226K	0.02%	555
2024 Q1	$14.9M	Buy	75,391 +2,427	+3%	+$445K	0.02%	569
2023 Q4	$12.6M	Sell	72,964 -461	-0.6%	-$70.8K	0.01%	592
2023 Q3	$10.9M	Buy	+73,425	New	+$13.3M	0.01%	602

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pictet Asset Management's RMD Position: Q2 2026 in Review

Pictet Asset Management increased its ResMed (RMD) stake by 42% in Q2 2026, buying an estimated $5.34M and bringing the position to 87,286 shares worth $17M. The position accounts for 0.02% of the portfolio, ranked #576.

Pictet Asset Management first reported a position in RMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $31.9M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Pictet Asset Management held 87,286 shares of ResMed worth $17M as of Q2 2026.
Pictet Asset Management bought 25,788 ResMed shares in Q2 2026, an estimated $5.34M.
ResMed made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #576 holding.
Pictet Asset Management first reported a position in ResMed in Q3 2023 and has held it in 12 quarters since.
Pictet Asset Management's ResMed position peaked at $31.9M in Q3 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.